Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.
Press releases published on April 7, 2025
AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
GlobeNewswire
·
April 7, 2025
OCALA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (OTC Pink: AIMI) — an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral …
AMMWEC & Muslim Women Speakers Join Muslims Israel Dialogue for a Historic Gathering Promoting Peace & Healing
EIN Presswire
·
April 7, 2025
WASHINGTON DC, DC, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- Former Hostages, Muslim Leaders, and Interfaith Allies to Unite in New York City for Historic Gathering Promoting Peace and Healing On April 9, 2025, nine former Israeli hostages— …
BON Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments
GlobeNewswire
·
April 7, 2025
XI’AN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced between October 2024 to January 2025, …
XTL Names Mr. Noam Band as its New Chief Executive Officer
GlobeNewswire
·
April 7, 2025
Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”) announced today the appointment of Noam Band as the Company’s …
California Resources Corporation Schedules First Quarter 2025 Earnings Conference Call
GlobeNewswire
·
April 7, 2025
LONG BEACH, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) plans to release its first quarter 2025 financial results on Tuesday, May 6th after market close. The Company will hold a conference call to discuss these …
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
GlobeNewswire
·
April 7, 2025
Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding and function Findings have potentially broad-ranging clinical relevance for multiple hepatobiliary diseases including progressive familial …
Rail Vision Announces Participation in the LD Micro Invitational XV
GlobeNewswire
·
April 7, 2025
Ra’anana, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, announced today …
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
GlobeNewswire
·
April 7, 2025
Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 CAR T Specifically Designed to Enhance Therapeutic Benefit, Expanding Treatment Potential Across a …
DeflationCoin Launches to Fix Bitcoin’s Flaws with Burn-Based Model and Smart Staking
GlobeNewswire
·
April 7, 2025
Dubai, UAE, April 07, 2025 (GLOBE NEWSWIRE) -- DeflationCoin formally launched a groundbreaking cryptocurrency with the purpose of fixing the economic and technological shortcomings of Bitcoin and Ethereum. The team is introducing a hard cap on the total …
Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
GlobeNewswire
·
April 7, 2025
RA'ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced the successful completion of …
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
GlobeNewswire
·
April 7, 2025
EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine …
Integral Metals Commences Phase I Exploration at KAP Project in Partnership with GeoCraft Geological Services
GlobeNewswire
·
April 7, 2025
CALGARY, Alberta, April 07, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the engagement of GeoCraft Geological Services Corp. (“GeoCraft”) to conduct Phase 1 …
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
GlobeNewswire
·
April 7, 2025
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ALX2004, the company’s first ADC, was fully designed …
Vital Battery Metals Announces Letter of Intent to Acquire the Corvo Uranium Project in the Athabasca Basin
GlobeNewswire
·
April 7, 2025
Corvo Uranium Project Highlights More than 29 km of exploration strike length along three strong NE-SW magnetic low trends coincident with EM conductors and cross-cutting faults, providing highly prospective shallow drill targets. Uranium mineralization is …
Aspargo Labs Expands Global Leadership Team
GlobeNewswire
·
April 7, 2025
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in …
Dundee Precious Metals Annual and Special Meeting of Shareholders to be held May 7, 2025
GlobeNewswire
·
April 7, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces its Annual and Special Meeting of Shareholders will be held on Wednesday, May 7, 2025, at 4 PM EDT via live audio webcast. Materials for …
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
GlobeNewswire
·
April 7, 2025
If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, addressing the high unmet need for …
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
GlobeNewswire
·
April 7, 2025
Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid Medicine Live and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or …
Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer
GlobeNewswire
·
April 7, 2025
WALTHAM, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …
Gilat Awarded Up to $23 Million Multi-Year Contract to Service Satellite Transportable Terminal Units for US DoD Customers
GlobeNewswire
·
April 7, 2025
PETAH TIKVA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat Defense was awarded a contract to …